About Us

About NEUREAL

Pioneer in Non-invasive Brain-Computer Interface

7
Registration Certificate
1000+
Institutions/Hospitals
80+
Patents
Nearly 100 million
Financing
Company

About Us

NEUREAL, a national specialized and innovative "Little Giant" enterprise, focuses on non-invasive brain-computer interface (BCI) technology. The company is dedicated to the direction of "cognitive and emotional BCI," focusing on decoding emotions and cognition. It applies cutting-edge technologies such as AI, BCI, VR, DCBT, and tDCS to clinical settings, serving individuals with brain function disorders including depression, ADHD, autism, and cognitive decline. It covers three major scenarios: hospital clinical, adolescent psychological intervention, and home-based brain health. Decoding emotions and cognition to improve brain health.

Milestones

Development Milestones

2016
Company establishment, initiating the technology validation phase
2020
Obtained the first Class II medical device registration certificate for DCBT in psychiatry in China, completing the certification for digital therapeutics VR treatment
2022
Acquired new registration certificates and Southeast Asian certifications, completing pre-A round financing of several million yuan
2023
Introduced brain science experts to initiate AI brain research, laying out BCI technology reserves
2025
Recognized as a national "Little Giant" enterprise in the BCI field, completing tens of millions of yuan in A+ round financing
2026
BCI pipeline entered pre-clinical stage, self-developed immersive BCI, won multiple prestigious awards including the Frost & Sullivan Global Non-invasive Brain-Computer Interface Company of the Year Award and the National Medical Insurance Innovation Scenario Competition Award.
Contact

Contact Us

Address: 12F, Building D, China (Hangzhou) Smart Information Industrial Park, Gongshu District, Hangzhou

Phone:400-992-8712

Email:xuzhishi@xuzhishi.com